(November 4, 2019, 1:45 PM EST) -- WASHINGTON, D.C. — Allergan Inc. on Nov. 1 told a federal judicial panel that it does not opposed centralization of 17 federal medical monitoring lawsuits involving Biocell textured breast implants but says the U.S. District Court for the District of New Jersey would be a better transferee court (In Re: Allergan Biocell Breast Implant Litigation, MDL Docket No. 2921, JPMDL)....